HOME >> MEDICINE >> NEWS
Melanoma research receives a massive funding boost

NSW cancer researchers from the Sydney Melanoma Unit have received over $11 million to advance their world-leading research into the diagnosis and treatment of melanoma.

Australians have the highest rate of melanoma in the world, with incidence levels up to four times higher than the US and the UK, and up to ten times higher than most other countries.

Whilst it is the third most common cancer in Australia, it has proved to be one of the most difficult to manage. It most commonly affects those in the 30-45 year age group - people in the prime of their life- yet standard cancer treatments are often ineffective.

The Sydney Melanoma Unit is a group of cancer researchers and clinicians drawn from Westmead Millennium Institute, Newcastle Mater and Royal Prince Alfred Hospitals. It runs the largest melanoma treatment centre in the world, and with associated expertise in molecular diagnosis and treatment, provides our best hope for improving outcomes in people who develop, or are at risk of developing, melanoma.

This research group was recently recognised with a $3.75 million Program Grant from the Cancer Institute NSW. Today the Hon Tony Abbott, Commonwealth Minister for Health, announced that the Unit has also been awarded a prestigious National Health and Medical Research Council Program Grant, providing a further $7.8 million to support its vital research.

"Melanoma cells that have spread from their site of origin are notorious for being resistant to cancer treatment such as chemotherapy and radiotherapy" says Professor Richard Kefford, Chief Investigator of the successful Sydney Melanoma Unit NHMRC grant and researcher at Westmead Millennium Institute.

"These funds will allow us to progress our research into the molecular factors that determine an individual's risk of melanoma, so that we can identify the type of melanoma they have and how that disease will respond to treatments. We can then create more effective treatme
'"/>

Contact: Gayle McNaught
gayle_mcnaught@wmi.usyd.edu.au
61-298-459-009
Research Australia
6-Jul-2005


Page: 1 2

Related medicine news :

1. Summer update: Melanoma research progress suggests optimism for future cures
2. Melanoma vaccine strategy shows promise in laboratory experiments
3. Melanoma risk only partially associated vith exposure to UVB from sunlight
4. 1 of 2 pediatric kidney disease research centers in world established
5. Stanford researchers find culprit in aging muscles that heal poorly
6. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
7. Indiana University Imaging Center receives $6M grant for kidney research
8. Penn researchers discover novel pathway for increasing good cholesterol
9. New research discovers independent brain networks control human walking
10. Theory of facial aging gets a facelift from UT Southwestern researchers
11. Sports concussion research using fMRI provides insight for safe return-to-play decisions

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Melanoma research receives massive funding boost

(Date:11/22/2014)... November 22, 2014 "My friend went ... caused by the machine," said an inventor from Cambria ... to go back a second time because the first ... , She developed the patent-pending MAMO EASY to offer ... The design saves the patient from the pain normally ...
(Date:11/22/2014)... Lipitor lawsuits ( http://www.lipitorlawsuitcenter.com/ ) that ... developed Type 2 diabetes due to its use continue ... underway in U.S. District Court, District of South Carolina, ... litigation will convene its next Status Conference on December ... Counsel for Plaintiffs and Defendants to meet and confer, ...
(Date:11/22/2014)... Eugene, OR (PRWEB) November 22, 2014 The ... addition of Roy Baroff to its team of ... lawyer, mediator, soccer player, coach, and referee. He has over ... North Carolina and beyond. , “I'm very excited to connect ... experience and sports related interests to a program with a ...
(Date:11/22/2014)... Columbus, OH (PRWEB) November 22, 2014 ... trials for AndroGel side-effects lawsuits have been scheduled ... District Court, Northern District of Illinois. U.S. District Judge ... litigation, issued a Case Management Order (CMO) on November ... as deadlines for attorneys to submit documents and other ...
(Date:11/22/2014)... Steven Reinberg HealthDay Reporter ... outcomes are better when patients are treated in an ambulance ... drugs, German researchers report. The sooner patients get the ... the outcome after a stroke, the researchers noted. For the ... first hour after stroke symptoms start, the researchers said. ...
Breaking Medicine News(10 mins):Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 2Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 3Health News:SCI Announces New Team Member Roy Baroff 2Health News:SCI Announces New Team Member Roy Baroff 3Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 2Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 3Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 4Health News:Special Ambulance Delivers Vital Stroke Care More Quickly 2Health News:Special Ambulance Delivers Vital Stroke Care More Quickly 3
(Date:11/22/2014)... 21, 2014 Many power shifts are ... influence of patients in the biopharmaceutical market is ... more than ever, understanding how to effectively acquire, ... is essential. According to recent ... companies spent about two-thirds of their patient-focused dollars ...
(Date:11/21/2014)... 2014 In September 2014, the staff at ... a new product development plan that started with the ... lab coat , aptly named "Vera G.," after ... the world. The new women,s designer lab coat is ... sleek envelope collar, vertical princess and high waist seaming, ...
(Date:11/21/2014)... 21, 2014  PTC Therapeutics, Inc. (NASDAQ: PTCT ... Technology Award for Vision, Innovation, and Leadership has been awarded ... This award recognizes an individual who has had a significant ... for several decades. "I am honored ... Stuart Peltz , Ph.D., CEO of PTC Therapeutics, Inc. "When ...
Breaking Medicine Technology:New Report Details Importance of Adopting a "Patient Journey" Framework in Marketing 2Medelita Introduces Medical Industry's First Limited Edition Women's Designer Lab Coat 2PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 2PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 3
Cached News: